February 10, 2026 · Form 4 insider transaction
Kewalramani Reshma sold 8,297 shares of Vertex Pharmaceuticals Incorporated at $468.41 per share, a transaction worth $3.89M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.